Evolus Inc diskutieren
Evolus Inc
WKN: A2JDYX / Symbol: EOLS / Name: Evolus / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
?
1,75 %
Evolus, Inc. (NASDAQ: EOLS) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $22.00 price target on the stock.
Ratings data for EOLS provided by MarketBeat
Evolus, Inc. (NASDAQ: EOLS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $27.00 price target on the stock.
Ratings data for EOLS provided by MarketBeat
Evolus, Inc. (NASDAQ: EOLS) had its price target raised by analysts at Barclays PLC from $20.00 to $22.00. They now have an "overweight" rating on the stock.
Ratings data for EOLS provided by MarketBeat
Evolus, Inc. (NASDAQ: EOLS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $27.00 price target on the stock.
Ratings data for EOLS provided by MarketBeat
Evolus, Inc. (NASDAQ: EOLS) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $22.00 price target on the stock.
Ratings data for EOLS provided by MarketBeat
Evolus, Inc. (NASDAQ: EOLS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $27.00 price target on the stock.
Ratings data for EOLS provided by MarketBeat
Evolus, Inc. (NASDAQ: EOLS) had its price target raised by analysts at Barclays PLC from $22.00 to $25.00. They now have an "overweight" rating on the stock.
Ratings data for EOLS provided by MarketBeat
Evolus, Inc. (NASDAQ: EOLS) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $22.00 price target on the stock.
Ratings data for EOLS provided by MarketBeat
Evolus, Inc. (NASDAQ: EOLS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $27.00 price target on the stock.
Ratings data for EOLS provided by MarketBeat
Evolus, Inc. (NASDAQ: EOLS) is now covered by analysts at BTIG Research. They set a "buy" rating and a $21.00 price target on the stock.
Ratings data for EOLS provided by MarketBeat
Evolus, Inc. (NASDAQ: EOLS) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $22.00 price target on the stock.
Ratings data for EOLS provided by MarketBeat
Evolus, Inc. (NASDAQ: EOLS) had its price target lowered by analysts at HC Wainwright from $27.00 to $20.00. They now have a "buy" rating on the stock.
Ratings data for EOLS provided by MarketBeat
Evolus, Inc. (NASDAQ: EOLS) had its price target lowered by analysts at BTIG Research from $21.00 to $18.00. They now have a "buy" rating on the stock.
Ratings data for EOLS provided by MarketBeat
Evolus (NASDAQ:EOLS) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $18.00 price target on the stock.
Ratings data for EOLS provided by MarketBeat
Neueste Beiträge
BMO_Capital_Markets in Atco Ltd NV diskutieren